On June 2, 2025, Sutro Biopharma, Inc. announced the appointment of Gregory K. Chow as Chief Financial Officer, effective the same day, with an annual salary of $475,000 and a target cash bonus of 40%. Chow will also receive options to purchase 275,000 shares and 100,000 restricted stock units pursuant to the company's equity plan.